The programme brings together world leaders from international pharmaceutical organisations and leading biotechnology companies as well as globally active regulatory agencies to discuss the latest in organoid discovery.
Access the conference brochure for presentation details, topic areas and confirmed speakers for our Virtual Symposium: Organoid Discovery.
Full Registration is now open for Virtual Symposium: Organoid Discovery. Please click the button below to register for this event.
Our LinkedIn group aims to foster discussion and collaboration between experts interested in the latest tools and strategies for organoid discovery.
Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions working within organoid discovery
The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future
Below were some of the speakers of 2020’s Discovery Series: Virtual
Karolinska Institute and SciLifeLab
Skaggs School Of Pharmacy And Pharmaceutical Sciences, University Of Colorado Anschutz Medical Campus
NMI Natural and Medical Sciences Institute at the University of Tübingen
F. Hoffmann-La Roche Innovation Center Basel
Karlsruhe Institute of Technology
Hubrecht Organoid Technology
Networking and knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
Crown Bioscience, a JSR Life Sciences company, is a global drug discovery and development services company providing translational platforms to advance oncology, immunology, inflammation, and metabolic disease research. Our biomarker discovery, validation, and assay services help our clients to successfully advance their preclinical and clinical therapeutic candidates.